🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ABV
$ABVX.PA
🔒 EuropeABIVAX
AVG HISTORICAL GAP
-1.98%
MAX GAP RECORD
-6.03%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ABVX.PA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ABVX.PA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Sep 21, 2026 Earnings Release 2026-09-21 (AFTER CLOSE (17:00)) |
-1.88%
|
| May 22, 2026 Earnings Release 2026-05-22 (AFTER CLOSE) |
+1.98%
|
| Mar 23, 2026 Earnings Release 2026-03-23 (BEFORE OPEN) |
-6.03%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.3%
Bullish Gaps (1)
Bearish Gaps (2)
Neutral / Flat (0)
📖 Intelligence Summary
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗